World Anti-Doping Agency

WADA addresses the 10th Session of the Conference of Parties to the UNESCO International Convention against Doping in Sport

This week, the World Anti-Doping Agency’s Director General, Olivier Niggli, and Director of Government Relations, Darren ...
World Anti-Doping Agency

WADA signs host contracts with Peru and Ecuador for Global Anti-Doping Intelligence and Investigations Network workshops

Intelligence and Investigations (I&I) Department, Günter Younger, and representatives from WADA’s Latin America and Caribbean ...
World Anti-Doping Agency

WADA publishes Independent Observer team report for the Paris 2024 Olympic Games

The World Anti-Doping Agency (WADA) has published its Independent Observer (IO) team report regarding the anti-doping program of the Paris 2024 Olympic Games, which were held in Paris, France from 26 ...
WADA

International Standard for Code Compliance by Signatories (ISCCS)

The International Standard for Code Compliance by Signatories (ISCCS) is a mandatory International Standard developed as part of the World Anti-Doping Program. The purpose of the ISCCS is to set out ...
WADA

Independent Observer Program

Ever since it was first launched at the 2000 Olympic Games in Sydney, WADA's Independent Observer (IO) program has helped enhance athlete and public confidence at major sport events by randomly ...
WADA

The effect of formoterol on blood, urine and muscle metabolism, prolonged endurance performance and sprinting ability in trained endurance athletes

Beta2-agonists are commonly used by elite endurance athletes to counteract asthma and exercise-induced bronchoconstriction, whereby more than 50% of athletes experience lower airways dysfunction.
WADA

Studies of glucocorticoids after intravenous administration: evaluation of washout periods.

Glucocorticoids (GC) are forbidden in sports competitions when used by injectable, oral or rectal routes. They are allowed by other routes for therapeutic purposes. Since most GCs are marketed in ...